Administration of Octreotide for Management of Postoperative High-Flow Chylothorax

Fabio Barili, Gianluca Polvani, Veli K. Topkara, Luca Dainese, Maurizio Roberto, Emad Aljaber, Massimo Bettoni, Faisal H. Cheema, Piero Trabattuni, Alessandro Parolapi, Rita Spirito, Paolo Biglioli

Research output: Contribution to journalArticlepeer-review


Chylothorax is a rare complication of adult cardiothoracic surgery that can affect the postoperative course as it can lead to respiratory insufficiency, protein loss, fluid imbalance, and immunodeficiency. We report the case of a 51-year-old man who developed a persistent high-flow chylothorax after replacement of the descending thoracic aorta for an aneurysm. After a week of complete oral intake cessation and total parenteral nutrition, we started administration of octreotide, a somatostatin analog. It led to rapid cessation of chyle production, and the patient was discharged without further complications and chylothorax relapses.

Original languageEnglish
Pages (from-to)90-92
Number of pages3
JournalAnnals of Vascular Surgery
Issue number1
Publication statusPublished - Jan 2007

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Administration of Octreotide for Management of Postoperative High-Flow Chylothorax'. Together they form a unique fingerprint.

Cite this